Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients
Rehabilitation after acute coronary syndrome includes visits to the cardiologist's office at 1, 2, 6 and 12 months after discharge. Due to the Covid-19 pandemic, visiting a cardiologist's office maybe impossible. In such cases telemedicine follow-up visit would be reasonable choice. Taking into account the absence of studies in this area, providing investigation evaluating parameters of safety for both methodics is relevant.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telemedicine FU | Experimental | Telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital. |
|
| Office FU | Active Comparator | Office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telemedicine FU | Other | Participant will get telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital. |
|
| Measure | Description | Time Frame |
|---|---|---|
| MACCE | Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| High level of MT optimization | High Level of Medical Therapy Optimization is defined as a participant meeting all of the following goals: LDL < 1.4 mmol/L and on any statin, blood pressure < 140/90 mm/Hg (<135/85 mm/Hg for patients with diabetes mellitus), on aspirin or other antiplatelet or anticoagulant, and not smoking. High level of medical therapy optimization is missing if any of the individual goals are missing. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ivan S Bessonov, MD, PhD | Tyumen Cardiology Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science | Tyumen | 625026 | Russia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054058 | Acute Coronary Syndrome |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Office FU | Other | Participant will get office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital. |
|
| 1 year |
| PB < 140/90 mm/Hg (<135/85 mm/Hg for Diabetes) | Blood pressure < 140 mm/Hg (<135/85 mm/Hg for for patients with diabetes mellitus) | 1 year |
| LDL < 1.4 mmol/L | Low density lipoprotein< 1.4 mmol/L | 1 year |
| Not smoking | Not smoking | 1 year |
| Decrease in overweight | Decrease in overweight | 1 year |
| Aspirin or other antiplatelet or anticoagulant | Adherence to aspirin or other antiplatelet or anticoagulant | 1 year |
| Adherence to prescribed medication | Adherence to prescribed at discharge medication | 1 year |
| Hospitalization | Hospitalization for cardiac reasons | 1 year |